Clinical trial · Observational
Analysis of Skin Lesions for Melanoma Presence by Volatile Spectroscopy Techniques
NCT02393001CI-TRIAL-00039697completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this research study is to determine if a very sensitive chemistry lab analyzer can be used to smell a skin cancer (like melanoma) similar to some dogs.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Melanoma | Melanoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Dermatology patients | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Dermatology patients
- description
- Patients seen in the dermatology clinic with suspicious skin lesion to be biopsied will have 4 skin swabs, 2 of the skin lesion and 2 of an area of unafflicted skin.
- interventionNames
- Other: Dermatology patients
Primary outcomes (1)
- measure
- Compare the off line spectral analyses of saline and alcohol skin swabs of normal control, melanoma negative and melanoma positive skin biopsies.
- timeFrame
- 1 day
- description
- Determine if the melanomas have unique identifying spectra that might be applied to noninvasive melanoma skin cancer screening in lieu of taking a biopsy
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * 18 years of age or older * Seen at the dermatology clinic \& determined to need a skin biopsy of a suspicious lesion Exclusion Criteria: * \< 18 years of age
References
Publications (0)
Data not yet available
No reference posted for this study.